Avalyn Pharma Inc.

Avalyn Pharma Inc. financial statements

Avalyn Pharma Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 85.2MEODHD
Cash and equivalentsUSD 52.31MEODHD
Total debtUSD 1.67MEODHD

Avalyn Pharma Inc. financials on 6ix · Avalyn Pharma Inc. on 6ix